Life Extension launches NitroVasc Boost on-the-go berry-flavored powder for circulatory support
March 19, 2020 10:00 ET | Life Extension
Fort Lauderdale, Fla., March 19, 2020 (GLOBE NEWSWIRE) -- Promoting heart health and blood flow has never been more convenient—or delicious. Life Extension® today announced the launch of NitroVasc™...
Dr. Bristow
ARCA biopharma Announces Fiscal Year 2019 Financial Results and Provides Corporate Update
February 18, 2020 16:30 ET | ARCA biopharma, Inc.
U.S. FDA Special Protocol Assessment agreement for a single pivotal Phase 3 clinical trial (PRECISION-AF) of genetically-targeted GencaroPRECISION-AF clinical trial initiation anticipated fourth...
Reports and Data.jpeg-01
Cardiovascular Ultrasound System Market To Reach USD 2.26 Billion By 2027 | Reports and Data
February 18, 2020 10:00 ET | Reports and Data
New York, Feb. 18, 2020 (GLOBE NEWSWIRE) -- The Global Cardiovascular Ultrasound System Market is forecast to reach USD 2.26 Billion by 2027, according to a new report by Reports and Data....
Reports and Data.jpeg-01
Optical Coherence Tomography Market To Reach USD 2.29 Billion By 2027 | Reports And Data
February 13, 2020 11:00 ET | Reports and Data
New York, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The global optical coherence tomography market is forecast to reach USD 2.29 Billion by 2027, according to a new report by Reports and Data. Optical...
Logo.png
PetVivo Holdings, Inc. Featured in New Research Update
September 26, 2019 08:00 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, MN, Sept. 26, 2019 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV), an emerging biomedical device company, is very pleased to announce that Marble Arch Research Inc., a leading...
ARCA Logo - JPEG.jpg
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium
September 12, 2019 08:30 ET | ARCA biopharma, Inc.
WESTMINSTER, Colo., Sept. 12, 2019 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted...
gmi 2018.png
European Next Generation Sequencing Market to achieve 19%+ CAGR up to 2025: Global Market Insights, Inc.
August 28, 2019 04:11 ET | Global Market Insights, Inc
Selbyville, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Global Market Insights, Inc., announces a report on ‘Next generation sequencing market 2019-2025 Trends & Forecast’. The study covers the product,...
RVX_logo_RGB.jpg
Resverlogix to Present at the European Society of Cardiology’s ESC Congress 2019
August 14, 2019 08:30 ET | Resverlogix Corp
CALGARY, Alberta, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) announces today that it will present at ESC Congress 2019, held this year in Paris,...
Digital Therapeutics Market To Reach USD 0.89 Billion By 2026 | Reports And Data
July 16, 2019 09:58 ET | Reports and Data
New York, July 16, 2019 (GLOBE NEWSWIRE) -- The rising awareness, research and development, technological advancements and launch of novel products with enhanced efficiency are the key factors...
RVX_logo_RGB.jpg
Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
July 08, 2019 08:30 ET | Resverlogix Corp
CALGARY, Alberta, July 08, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) is pleased to announce today that all patients active in BETonMACE, the Company’s...